Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer

NCT06788366 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06788366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06788366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
February 12, 2024
Completion date
December 31, 2026
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc stage iv